Skip to main content
Erschienen in: Journal of Cancer Education 3/2018

08.12.2016

Assessing Colorectal Cancer Screening Barriers by Two Methods

verfasst von: Mira L. Katz, Gregory S. Young, Barret J. Zimmermann, Cathy M. Tatum, Electra D. Paskett

Erschienen in: Journal of Cancer Education | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer (CRC) is commonly diagnosed in the USA despite screening tests that have decreased CRC incidence and mortality. Finding the best method to identify patient-level screening barriers is important to improve CRC screening rates. A group-randomized trial was conducted among ten primary-care clinics. Clinics were randomized to a multi-level (clinic, provider, patient) CRC screening intervention or usual care (2007–2013). Subsequent to clinic- and provider-level interventions, a three-step, patient-level intervention was conducted. One step of the patient-level intervention was a CRC screening barriers counseling call conducted by a lay health advisor (LHA). During the call, two methods were used to identify CRC screening barriers. An open-ended question was used first to determine why participants had not completed screening (without probes). Subsequently, the LHA read a list of additional potential screening barriers and asked participants whether each barrier was applicable (with probes). A generalized estimating equation approach was used to compare the two methods. Participants (n = 109) were female (59%), had a mean age of 57.2 years, and were white (67%) or black (31%). Most participants had some college education or a college degree (79%), annual household income $30,000+ (60%), and health insurance (80%). The number of CRC screening barriers increased with probing compared to the open-ended question format (OR 2.10, 95% CI 1.92–2.31; p < 0.01). The ranking of reported CRC screening barriers did not vary by assessment method. However, the methodology used to document CRC screening barriers may influence the content of patient-directed interventions.
Literatur
1.
Zurück zum Zitat American Cancer Society (2016) Cancer facts and figures, 2016. American Cancer Society, Atlanta American Cancer Society (2016) Cancer facts and figures, 2016. American Cancer Society, Atlanta
2.
Zurück zum Zitat American Cancer Society (2014) Colorectal cancer facts and figures, 2014–2016. American Cancer Society, Atlanta American Cancer Society (2014) Colorectal cancer facts and figures, 2014–2016. American Cancer Society, Atlanta
3.
Zurück zum Zitat Chowdhury PP, Mawokomatanda T, Xu F, Gamble S, Flegel D, Pierannunzi C, Garvin W, Town M (2016) Surveillance for certain health behaviors, chronic diseases, and conditions, access to health care, and use of preventive health services among states and selected local areas-behavioral risk factor surveillance system, United States, 2012. MMWR Surveill Summ 65(4):1–142CrossRefPubMed Chowdhury PP, Mawokomatanda T, Xu F, Gamble S, Flegel D, Pierannunzi C, Garvin W, Town M (2016) Surveillance for certain health behaviors, chronic diseases, and conditions, access to health care, and use of preventive health services among states and selected local areas-behavioral risk factor surveillance system, United States, 2012. MMWR Surveill Summ 65(4):1–142CrossRefPubMed
4.
Zurück zum Zitat Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health centers for population health and health disparities. Am J Public Health 98(9):1608–1615CrossRefPubMedPubMedCentral Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health centers for population health and health disparities. Am J Public Health 98(9):1608–1615CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Honein-AbouHaidar GN, Kastner M, Vuoung V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomark Prev 25:907–917CrossRef Honein-AbouHaidar GN, Kastner M, Vuoung V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomark Prev 25:907–917CrossRef
6.
Zurück zum Zitat Jones RM, Devers KJ, Kuzel AJ, Woolf SH (2010) Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med 38(5):508–516CrossRefPubMedPubMedCentral Jones RM, Devers KJ, Kuzel AJ, Woolf SH (2010) Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med 38(5):508–516CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jillcott-Pitts SB, Lea CS, May CL, Stowe C, Hamill DJ, Walker KT, Fitzgerald TL (2013) “Fault-line of an earthquake”: a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, eastern North Carolina. J Rural Health 29(1):78–87CrossRef Jillcott-Pitts SB, Lea CS, May CL, Stowe C, Hamill DJ, Walker KT, Fitzgerald TL (2013) “Fault-line of an earthquake”: a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, eastern North Carolina. J Rural Health 29(1):78–87CrossRef
8.
Zurück zum Zitat Martens CE, Crutchfield TM, Laping JL, Perreras L, Reuland DS, Cubillos L, Pignone MP, Wheeler SB (2015) Why wait until our community gets cancer?: exploring CRC screening barriers and facilitators in the Spanish-speaking community in North Carolina. J Cancer Educ. doi:10.1007/s13187-015-0890-4 Martens CE, Crutchfield TM, Laping JL, Perreras L, Reuland DS, Cubillos L, Pignone MP, Wheeler SB (2015) Why wait until our community gets cancer?: exploring CRC screening barriers and facilitators in the Spanish-speaking community in North Carolina. J Cancer Educ. doi:10.​1007/​s13187-015-0890-4
9.
Zurück zum Zitat May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BM (2015) Addressing low colorectal cancer screening in African Americans: using focus groups to inform the development of effective interventions. J Cancer Educ. doi:10.1007/s13187-015-0842-z May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BM (2015) Addressing low colorectal cancer screening in African Americans: using focus groups to inform the development of effective interventions. J Cancer Educ. doi:10.​1007/​s13187-015-0842-z
10.
Zurück zum Zitat McAlearney AS, Reeves KW, Dickinson SL, Kelly KM, Tatum C, Katz ML, Paskett ED (2008) Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer 112(2):391–398 McAlearney AS, Reeves KW, Dickinson SL, Kelly KM, Tatum C, Katz ML, Paskett ED (2008) Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer 112(2):391–398
11.
Zurück zum Zitat Kiviniemi MT, Jandorf L, Erwin DO (2014) Disgusted, embarrassed, annoyed: affective associations relate to uptake of colonoscopy screening. Ann Behav Med 48(1):112–119CrossRefPubMedPubMedCentral Kiviniemi MT, Jandorf L, Erwin DO (2014) Disgusted, embarrassed, annoyed: affective associations relate to uptake of colonoscopy screening. Ann Behav Med 48(1):112–119CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ritvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L (2013) Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health. doi:10.1186/1471-2458-13-500 Ritvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L (2013) Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health. doi:10.​1186/​1471-2458-13-500
13.
Zurück zum Zitat Young WF, McGloin J, Zittleman L, West DR, Westfall JM (2007) Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health 23(3):238–245CrossRefPubMed Young WF, McGloin J, Zittleman L, West DR, Westfall JM (2007) Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health 23(3):238–245CrossRefPubMed
14.
Zurück zum Zitat Basch CH, Basch CE, Zybert P, Wolf RL (2016) Fear as a barrier to asymptomatic colonoscopy screening in an urban minority population with health insurance. J Community Health 41:818–824CrossRefPubMed Basch CH, Basch CE, Zybert P, Wolf RL (2016) Fear as a barrier to asymptomatic colonoscopy screening in an urban minority population with health insurance. J Community Health 41:818–824CrossRefPubMed
15.
Zurück zum Zitat Klabunde CN, Schenck AP, Davis WW (2006) Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 30(4):313–319CrossRefPubMed Klabunde CN, Schenck AP, Davis WW (2006) Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 30(4):313–319CrossRefPubMed
16.
Zurück zum Zitat Knight JR, Kanotra S, Siameh S, Jones J, Thompson B, Thomas-Cox S (2015) Understanding barriers to colorectal cancer screening in Kentucky. Prev Chronic Dis. doi:10.5888/pcd12.140586 PubMed Knight JR, Kanotra S, Siameh S, Jones J, Thompson B, Thomas-Cox S (2015) Understanding barriers to colorectal cancer screening in Kentucky. Prev Chronic Dis. doi:10.​5888/​pcd12.​140586 PubMed
17.
Zurück zum Zitat Hughes AG, Watanabe-Galloway S, Schnell P, Soliman AS (2015) Rural-urban differences in colorectal cancer screening barriers in Nebraska. J Community Health 40(6):1065–1074CrossRefPubMedPubMedCentral Hughes AG, Watanabe-Galloway S, Schnell P, Soliman AS (2015) Rural-urban differences in colorectal cancer screening barriers in Nebraska. J Community Health 40(6):1065–1074CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Murray DM, Katz ML, Post DM, Pennell ML, Young GS, Tatum CM, Paskett ED (2013) Enhancing cancer screening in primary care: rationale, design, analysis plan, and recruitment results. Contemp Clin Trials 34(2):356–363 Murray DM, Katz ML, Post DM, Pennell ML, Young GS, Tatum CM, Paskett ED (2013) Enhancing cancer screening in primary care: rationale, design, analysis plan, and recruitment results. Contemp Clin Trials 34(2):356–363
19.
Zurück zum Zitat Krok-Schoen JL, Young GS, Pennell ML, Reiter PL, Katz ML, Post DM, Tatum CM, Paskett ED (2015) Testing Interventions to Motivate and Educate (TIME): a multi-level intervention to improve colorectal cancer screening. Prev Med Rep 2:306–313 Krok-Schoen JL, Young GS, Pennell ML, Reiter PL, Katz ML, Post DM, Tatum CM, Paskett ED (2015) Testing Interventions to Motivate and Educate (TIME): a multi-level intervention to improve colorectal cancer screening. Prev Med Rep 2:306–313
20.
Zurück zum Zitat Liang K, Zeger S (2000) Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhyā: The Indian Journal of Statistics, Series B 62:134–148 Liang K, Zeger S (2000) Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhyā: The Indian Journal of Statistics, Series B 62:134–148
21.
Zurück zum Zitat Stimpson JP, Wilson FA, Watanabe-Galloway S, Peek MK (2012) The effect of marriage on utilization of colorectal endoscopy exam in the United States. Cancer Epidemiol 36(5):e325–e332CrossRefPubMedPubMedCentral Stimpson JP, Wilson FA, Watanabe-Galloway S, Peek MK (2012) The effect of marriage on utilization of colorectal endoscopy exam in the United States. Cancer Epidemiol 36(5):e325–e332CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kotwal AA, Lauderdale DS, Waite LJ, Dale W (2016) Differences between husbands and wives in colonoscopy use: results from a national sample of married couples. Prev Med 88:46–52CrossRefPubMedPubMedCentral Kotwal AA, Lauderdale DS, Waite LJ, Dale W (2016) Differences between husbands and wives in colonoscopy use: results from a national sample of married couples. Prev Med 88:46–52CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ (2014) The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 120(13):2025–2031CrossRefPubMed Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ (2014) The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 120(13):2025–2031CrossRefPubMed
24.
Zurück zum Zitat Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L (2015) Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiol Biomark Prev 24(3):506–511CrossRef Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L (2015) Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiol Biomark Prev 24(3):506–511CrossRef
25.
Zurück zum Zitat Ladabaum U, Mannalithara A, Jandorf L, Itzkowitz SH (2015) Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer 121(7):1088–1097CrossRefPubMed Ladabaum U, Mannalithara A, Jandorf L, Itzkowitz SH (2015) Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer 121(7):1088–1097CrossRefPubMed
Metadaten
Titel
Assessing Colorectal Cancer Screening Barriers by Two Methods
verfasst von
Mira L. Katz
Gregory S. Young
Barret J. Zimmermann
Cathy M. Tatum
Electra D. Paskett
Publikationsdatum
08.12.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2018
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1148-5

Weitere Artikel der Ausgabe 3/2018

Journal of Cancer Education 3/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.